Table 2.
Participant Hepatic Lipid Parameters
| All Participants (N = 25) | IHL of >5.56% (N = 8) | IHL of <5.56% (N = 17) | |
|---|---|---|---|
| IHL, % | 5 ± 4 | 11 ± 4 | 3 ± 1a |
| Palmitate uptake rate, nmol/g of liver/min | 8 ± 3 | 8 ± 3 | 7 ± 3 |
| Nonesterified palmitate concentration, µmol/g of liver | 0.41 ± 0.11 | 0.48 ± 0.11 | 0.38 ± 0.10b |
| TG palmitate concentration, µmol/g of liver | 7.3 ± 5.1 | 12.2 ± 5.9 | 5.0 ± 2.4b |
| Palmitoyl-carnitine concentration, µmol/g of liver | 0.15 ± 0.11 | 0.18 ± 0.10 | 0.14 ± 0.12 |
| Total DG concentration, nmol/mg of liver | 7.5 ± 7.1 | 11.2 ± 5.3 | 5.7 ± 7.2 |
| DG saturation index | 0.24 ± 0.06 | 0.21 ± 0.08 | 0.25 ± 0.05 |
| S1P concentration, nmol/g of liver | 1.08 ± 0.28 | 1.13 ± 0.31 | 1.06 ± 0.27 |
| Total ceramide concentration, nmol/g of liver | 215 ± 45 | 217 ± 56 | 214 ± 41 |
Data are represented as mean ± SD.
Abbreviation: S1P, sphingosine-1-phosphate.
a
Not subject to statistical testing because this is not a random variable.
b
P < 0.05 vs group with IHL >5.56%.